Drugs / Allogeneic human pulp mesenchymal stem cells
Allogeneic human pulp mesenchymal stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05728346 | Sep 2023 → Jun 2026 overdue | dental pulp necrosis | Fifth Affiliated Hospital of Guangzhou Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic human pulp mesenchymal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05728346 ↗ |
| Modality | Cell therapy | “stem cells from human exfoliated deciduous teeth (SHED)” NCT05728346 ↗ |